FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Derek Raghavan

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Maha Hussain; Subramanian Kanaga Sundaram; Glenn Liu; Carol M Moinpour; Stephen Prescott; David I Quinn; Derek Raghavan; Paul F Schellhammer; Eric Jay Small; Catherine M Tangen; Donna L Berry; E David Crawford; Nancy Ann Dawson; Bryan J Donnelly; Benjamin Ely; Celestia S Higano; Ulka N Vaishampayan; Peter M Venner; Nicholas J Vogelzang; George Wilding; Ian M Thompson
Intermittent versus continuous androgen deprivation in prostate cancer.
Elie Fahed; Donna E Hansel; David I Quinn; Derek Raghavan; Tanya B Dorff
Small cell bladder cancer: biology and management.
Toni K Choueiri; Derek Raghavan
Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Derek Raghavan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maha Hussain; Subramanian Kanaga Sundaram; Glenn Liu; Carol M Moinpour; Stephen Prescott; David I Quinn; Derek Raghavan; Paul F Schellhammer; Eric Jay Small; Catherine M Tangen; Donna L Berry; E David Crawford; Nancy Ann Dawson; Bryan J Donnelly; Benjamin Ely; Celestia S Higano; Ulka N Vaishampayan; Peter M Venner; Nicholas J Vogelzang; George Wilding; Ian M Thompson
Intermittent versus continuous androgen deprivation in prostate cancer.
The New England journal of medicine 2013;368(14):1314-25.
2012: Elie Fahed; Donna E Hansel; David I Quinn; Derek Raghavan; Tanya B Dorff
Small cell bladder cancer: biology and management.
Seminars in oncology 2012;39(5):615-8.
2008: Toni K Choueiri; Derek Raghavan
Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
Nature clinical practice. Oncology 2008;5(8):444-54.
2008: Alton Oliver Sartor; Catherine M Tangen; Maha Hussain; Mario A Eisenberger; Minoti Parab; Joseph A Fontana; Robert A Chapman; Glenn M Mills; Derek Raghavan; E David Crawford
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
Cancer 2008;112(11):2393-400.
2008: Thomas W Flaig; Catherine M Tangen; Maha Hussain; Walter M Stadler; Derek Raghavan; E David Crawford; L Michael Glodé
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1532-6.
2007: Tyler Y Kang; Peter Nichols; Eila Skinner; Susan Groshen; Greg Valin; Wei Ye; Derek Raghavan
Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response.
BJU international 2007;99(5):1024-7.
2006: Maha Hussain; Catherine M Tangen; Celestia S Higano; Paul F Schelhammer; James Faulkner; E David Crawford; George Wilding; Atif Akdas; Eric J Small; Bryan Donnelly; Gary R MacVicar; Derek Raghavan
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3984-90.
2006: Tomasz M Beer; Catherine M Tangen; Craig Nichols; Kim Margolin; Robert Dreicer; William T Stephenson; David I Quinn; Derek Raghavan; E David Crawford
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Cancer 2006;106(12):2624-9.
2006: Daniel P Petrylak; Donna Pauler Ankerst; Caroline S Jiang; Catherine M Tangen; Maha Hussain; Primo Lara; Jeffrey A Jones; Mary Ellen Taplin; Patrick A Burch; Manish Kohli; Mitchell C Benson; Eric J Small; Derek Raghavan; E David Crawford
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
Journal of the National Cancer Institute 2006;98(8):516-21.
2005: Derek Raghavan; L J Brandes; K Klapp; T Snyder; E Styles; Denice D Tsao-Wei; Gary Lieskovsky; David I Quinn; E W Ramsey
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases.
The Journal of urology 2005;174(5):1808-13; discussion 1813.
2004: Daniel P Petrylak; Catherine M Tangen; Maha Hussain; Primo Lara; Jeffrey A Jones; Mary Ellen Taplin; Patrick A Burch; Donna Berry; Carol M Moinpour; Manish Kohli; Mitchell C Benson; Eric J Small; Derek Raghavan; E David Crawford
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
The New England journal of medicine 2004;351(15):1513-20.
2004: Valerie Israel; Scott T Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan
Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC).
Investigational new drugs 2004;22(3):291-7.
2004: Derek Raghavan; Eila Skinner
Genitourinary cancer in the elderly.
Seminars in oncology 2004;31(2):249-63.
2004: Mario A Eisenberger; Menachem Laufer; Nicholas J Vogelzang; Oliver Sartor; Donald Thornton; Blake Lee Neubauer; Victoria Sinibaldi; Gary Lieskovsky; Michael A Carducci; Marianna Zahurak; Derek Raghavan
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action.
Urology 2004;63(1):114-9.
2003: Derek Raghavan
Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder.
Urologic oncology 2003;21(6):468-74.
2003: Marcus L Quek; John P Stein; Peter E Clark; Siamak Daneshmand; Gus Miranda; Jie Cai; Susan Groshen; Gary Lieskovsky; David I Quinn; Derek Raghavan; Donald G Skinner
Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
Cancer 2003;98(5):955-61.
2003: H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood Jr; Derek Raghavan; E David Crawford
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
The New England journal of medicine 2003;349(9):859-66.
2003: Derek Raghavan
Molecular targeting and pharmacogenomics in the management of advanced bladder cancer.
Cancer 2003;97(8 Suppl):2083-9.
2003: Derek Raghavan
Progress in the chemotherapy of metastatic cancer of the urinary tract.
Cancer 2003;97(8 Suppl):2050-5.
2003: Derek Raghavan
Testicular cancer: maintaining the high cure rate.
Oncology (Williston Park, N.Y.) 2003;17(2):218-28; discussion 228-9, 234-5, passim.
2002: Derek Raghavan; David Quinn; Donald G Skinner; John P Stein
Surgery and adjunctive chemotherapy for invasive bladder cancer.
Surgical oncology 2002;11(1-2):55-63.
2001: John P Stein; Gary Lieskovsky; Richard J Cote; Susan Groshen; An-Chen Feng; S Boyd; Eila C Skinner; Bernard H Bochner; Duraiyah Thangathurai; Maged Mikhail; Derek Raghavan; Donald G Skinner
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):666-75.
2000: D Parimoo; Derek Raghavan
Progress in the management of metastatic bladder cancer.
Cancer control : journal of the Moffitt Cancer Center 2000;7(4):347-56.